August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Study Identifies Age-Specific Prediabetes Mortality Risk

Researchers found in over 38,000 US adults that prediabetes was linked to higher mortality risk only in those aged 20 to 54 years.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Fast Walking Tied to Longer Life

As little as 15 minutes per day of fast walking was linked to 19% lower all-cause mortality.

Conexiant

August 27, 2025

Mass Spec Roundup: Worms, Phytoplankton, and SC Proteomics…

Plus more mass spec news…

The Analytical Scientist

August 22, 2025

Patient Awareness of Pharmacogenomic Testing Remains Low, ACS CAN Survey Reports

Less than half of responding patients with cancer were previously familiar with pharmacogenomic testing and its possible benefits, according to the results of a survey conducted by the American Cancer...

The ASCO Post

August 22, 2025

Survival in Older Patients With Cancer and Diabetes: GLP-1 RAs vs Other Glucose-Lowering Drugs

Glucagon-like peptide-1 (GLP-1) receptor agonists were found to be associated with lower all-cause mortality than dipeptidyl peptidase-4 (DPP-4) inhibitors, with no significant difference from sodium-...

The ASCO Post

August 22, 2025

Nivolumab Plus Ipilimumab in mCRPC With an Immunogenic Signature

In a UK phase II trial (NEPTUNES) reported in the Journal of Clinical Oncology, Leone et al evaluated the efficacy of nivolumab plus ipilimumab in previously treated patients with immunogenic signatur...

The ASCO Post

August 22, 2025

Investigating the Mechanisms of Cardiovascular Adverse Events Linked to Certain Cancer Treatments

The true upside of the many advances in cancer treatment is clear. Approximately 18.6 million people in the United States have a history of cancer, and the number of cancer survivors is expected to ex...

The ASCO Post